Advanced search
Publication Cover
Molecular and Cellular Biology Volume 33, 2013 - Issue 11
Submit an article Journal homepage
41
Views
41
CrossRef citations to date
0
Altmetric
Article

MicroRNA 9-3p Targets β1 Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition

Jon S. Zawistowskia Department of Pharmacology, RNAi Screening Facility, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;b Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
,
Kazuhiro Nakamuraa Department of Pharmacology, RNAi Screening Facility, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;b Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
,
Joel S. Parkerb Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;c Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
,
Deborah A. Grangera Department of Pharmacology, RNAi Screening Facility, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;b Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
,
Brian T. Golitza Department of Pharmacology, RNAi Screening Facility, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;b Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
&
Gary L. Johnsona Department of Pharmacology, RNAi Screening Facility, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA;b Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USACorrespondence[email protected]
Pages 2260-2274 | Received 07 Mar 2013, Accepted 19 Mar 2013, Published online: 20 Mar 2023

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lisa Svartdal Normann, Mads Haugland Haugen, Miriam Ragle Aure, Vessela N Kristensen, Gunhild Mari Mælandsmo & Kristine Kleivi Sahlberg. (2022) miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy. Breast Cancer: Targets and Therapy 14, pages 25-39.
Read now
Yu Ding, Yinghua Pan, Shan Liu, Feng Jiang & Junbo Jiao. (2017) Elevation of MiR-9–3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV. Cancer Biology & Therapy 18:6, pages 414-424.
Read now

Articles from other publishers (39)

Elham Allahyari, Kobra Velaei, Zohreh Sanaat, Nazila Jalilzadeh, Amir Mehdizadeh & Mohammad Rahmati. (2022) RNA interference: Promising approach for breast cancer diagnosis and treatment. Cell Biology International 47:5, pages 833-847.
Crossref
Maeirah Ashaie & Ezharul Hoque Chowdhury. (2021) Nanoparticles-Facilitated Intracellular Transport of siRNAs against Individual Integrin Subunits Inhibits Growth of Breast Cancer Cells. Applied Sciences 11:22, pages 10782.
Crossref
Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo & Kristine Kleivi Sahlberg. (2021) MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro. Scientific Reports 11:1.
Crossref
Martina Chiacchiarini, Sofia Trocchianesi, Zein Mersini Besharat, Agnese Po & Elisabetta Ferretti. (2021) Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer. Pharmacology & Therapeutics 219, pages 107708.
Crossref
Luyue Chen, Kai Huang, Kaikai Yi, Yanlin Huang, Xinhua Tian & Chunsheng Kang. (2020) Premature MicroRNA-Based Therapeutic: A “One-Two Punch” against Cancers. Cancers 12:12, pages 3831.
Crossref
Hidenori Kage, Per Flodby, Beiyun Zhou & Zea Borok. (2019) Dichotomous roles of claudins as tumor promoters or suppressors: lessons from knockout mice. Cellular and Molecular Life Sciences 76:23, pages 4663-4672.
Crossref
Lili Ren, Wenju Mo, Linling Wang & Xiaojia Wang. (2019) Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial‑to‑mesenchymal transition. Experimental and Therapeutic Medicine.
Crossref
Mengyun Su, Hong Yi, Xiaolei He, Longfei Luo, Shan Jiang & Ying Shi. (2019) miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment. Experimental Cell Research 384:1, pages 111615.
Crossref
Chang Bao, Yunkun Lu, Jishun Chen, Danni Chen, Weiyang Lou, Bisha Ding, Liang Xu & Weimin Fan. (2019) Exploring specific prognostic biomarkers in triple-negative breast cancer. Cell Death & Disease 10:11.
Crossref
Saswati Karmakar, Garima Kaushik, Ramakrishna Nimmakayala, Satyanarayana Rachagani, Moorthy P. Ponnusamy & Surinder K. Batra. (2019) MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Seminars in Cancer Biology 54, pages 63-71.
Crossref
Young Ran Park, Soo Teik Lee, Se Lim Kim, Shi Mao Zhu, Min Ro Lee, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Seung Young Seo & Sang Wook Kim. (2019) Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Cancer Genetics 231-232, pages 22-31.
Crossref
Jing Ye, Zhiqiu Yao, Wenyu Si, Xiaoxiao Gao, Chen Yang, Ya Liu, Jianping Ding, Weiping Huang, Fugui Fang & Jie Zhou. (2018) Identification and characterization of microRNAs in the pituitary of pubescent goats. Reproductive Biology and Endocrinology 16:1.
Crossref
Ilker Tinay, Mingyue Tan, Bin Gui, Lillian Werner, Adam S. Kibel & Li Jia. (2018) Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. The Prostate 78:12, pages 927-937.
Crossref
V. I. Loginov, E. A. Filippova, S. V. Kurevlev, M. V. Fridman, A. M. Burdennyy & E. A. Braga. (2018) Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer. Russian Journal of Genetics 54:7, pages 770-787.
Crossref
Yi Gu, Nan Yang, Leping Yin, Chao Feng & Tong Liu. (2018) Inhibitory roles of miR‑9 on papillary thyroid cancer through targeting BRAF. Molecular Medicine Reports.
Crossref
Katarzyna Nowek, Erik A.C. Wiemer & Mojca Jongen-Lavrencic. (2018) The versatile nature of miR-9/9* in human cancer. Oncotarget 9:29, pages 20838-20854.
Crossref
Nan Wu, Qing Zhu, Binlong Chen, Jian Gao, Zhongxian Xu & Diyan Li. (2017) High-throughput sequencing of pituitary and hypothalamic microRNA transcriptome associated with high rate of egg production. BMC Genomics 18:1.
Crossref
Amanda E D Van Swearingen, Maria J Sambade, Marni B Siegel, Shivani Sud, Robert S McNeill, Samantha M Bevill, Xin Chen, Ryan E Bash, Louisa Mounsey, Brian T Golitz, Charlene Santos, Allison Deal, Joel S Parker, Naim Rashid, C Ryan Miller, Gary L Johnson & Carey K Anders. (2017) Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. Neuro-Oncology 19:11, pages 1481-1493.
Crossref
Laure Malric, Sylvie Monferran, Julia Gilhodes, Sabrina Boyrie, Perrine Dahan, Nicolas Skuli, Julie Sesen, Thomas Filleron, Aline Kowalski-Chauvel, Elizabeth Cohen-Jonathan Moyal, Christine Toulas & Anthony Lemarié. (2017) Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update. Oncotarget 8:49, pages 86947-86968.
Crossref
Qingshun Meng, Longquan Xiang, Jingwei Fu, Xianqun Chu, Chunlin Wang & Bingzheng Yan. (2017) Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer. Oncotarget 8:23, pages 37321-37331.
Crossref
Ling Yang, Yongping Mu, Hongwei Cui, Yabing Liang & Xiulan Su. (2017) MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma. PLOS ONE 12:4, pages e0174839.
Crossref
Raffaela Barbano, Barbara Pasculli, Michelina Rendina, Andrea Fontana, Caterina Fusilli, Massimiliano Copetti, Stefano Castellana, Vanna Maria Valori, Maria Morritti, Paolo Graziano, Ciuffreda Luigi, Michelina Coco, Francesco Picardo, Tommaso Mazza, Ella Evron, Roberto Murgo, Evaristo Maiello, Manel Esteller, Vito Michele Fazio & Paola Parrella. (2017) Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients. Scientific Reports 7:1.
Crossref
Alyssa C. Lesko & Jenifer R. Prosperi. (2017) Epithelial Membrane Protein 2 and β1 integrin signaling regulate APC-mediated processes. Experimental Cell Research 350:1, pages 190-198.
Crossref
Xiangyang Miao, Qingmiao Luo, Huijing Zhao & Xiaoyu Qin. (2016) Genome-wide analysis of miRNAs in the ovaries of Jining Grey and Laiwu Black goats to explore the regulation of fecundity. Scientific Reports 6:1.
Crossref
Cheolwon Choi, Junyeob Kwon, Sunyoung Lim & David M. Helfman. (2016) Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer. Oncotarget 7:39, pages 63466-63487.
Crossref
Bing He, Yu-Feng Xiao, Bo Tang, Yu-Yun Wu, Chang-Jiang Hu, Rui Xie, Xin Yang, Song-Tao Yu, Hui Dong, Xiao-Yan Zhao, Ji-Liang Li & Shi-Ming Yang. (2016) hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a. Scientific Reports 6:1.
Crossref
Sukhontip Klahan, Wan-Chen Huang, Che-Mai Chang, Henry Sung-Ching Wong, Chi-Cheng Huang, Mei-Shin Wu, Yu-Chiao Lin, Hsing-Fang Lu, Ming-Feng Hou & Wei-Chiao Chang. (2016) Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer. Pharmacological Research 104, pages 31-37.
Crossref
Zhipeng Zou, Juan Chen, Anling Liu, Xuan Zhou, Qiancheng Song, Chunhong Jia, Zhenguo Chen, Jun Lin, Cuilan Yang, Ming Li, Yu Jiang & Xiaochun Bai. (2015) mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1. Journal of Cell Biology 211:1, pages 105-122.
Crossref
Sriganesh B. Sharma & John Michael Ruppert. (2015) MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer. Drug Development Research 76:6, pages 328-342.
Crossref
Andrea Weckman, Fabio Rotondo, Antonio Di Ieva, Luis V Syro, Henriett Butz, Michael D Cusimano & Kalman Kovacs. (2015) Autophagy in endocrine tumors. Endocrine-Related Cancer 22:4, pages R205-R218.
Crossref
T Higashi, H Hayashi, T Ishimoto, H Takeyama, T Kaida, K Arima, K Taki, K Sakamoto, H Kuroki, H Okabe, H Nitta, D Hashimoto, A Chikamoto, T Beppu & H Baba. (2015) miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. British Journal of Cancer 113:2, pages 252-258.
Crossref
Wei Ouyang, Yong-shan Wang, Xi-ning Du, Hua-jie Liu & Hai-bin Zhang. (2015) gga-miR-9* inhibits IFN production in antiviral innate immunity by targeting interferon regulatory factor 2 to promote IBDV replication. Veterinary Microbiology 178:1-2, pages 41-49.
Crossref
XIAO-HONG WANG, XIN-MIN YU, HONG JIANG & CONG LUO. (2015) Differential microRNA expression profiles in HCT116 colorectal cancer cell lines located in the lung and colon. Molecular Medicine Reports 11:4, pages 2903-2907.
Crossref
Fiorella Ciaffoni, Elena Cassella, Lilian Varricchio, Margherita Massa, Giovanni Barosi & Anna Rita Migliaccio. (2015) Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis. Blood Cells, Molecules, and Diseases 54:3, pages 234-241.
Crossref
Justin S. Gundara, JingTing Zhao, Anthony J. Gill, James C. Lee, Leigh Delbridge, Bruce G. Robinson, Catriona McLean, Jonathan Serpell & Stan B. Sidhu. (2014) Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer . Cancer Medicine 4:2, pages 174-182.
Crossref
Myriam Ben Dhiab, Sonia Ziadi, Teheni Louhichi, Riadh Ben Gacem, Feryel Ksiaa & Mounir Trimeche. (2015) Investigation of miR9-1, miR9-2 and miR9-3 Methylation in Hodgkin Lymphoma. Pathobiology 82:5, pages 195-202.
Crossref
Paola Nisticò, Francesca Di Modugno, Sheila Spada & Mina J Bissell. (2014) β1 and β4 integrins: from breast development to clinical practice. Breast Cancer Research 16:5.
Crossref
Yan Zhou, Hai-yan Hu, Wei Meng, Ling Jiang, Xing Zhang, Jing-jing Sha, Zhigang Lu & Yang Yao. (2014) MEK inhibitor effective against proliferation in breast cancer cell. Tumor Biology 35:9, pages 9269-9279.
Crossref
Sherif Abdelaziz Ibrahim, Hebatallah Hassan & Martin Götte. (2014) MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:8, pages 2609-2620.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.